1. Autophagy Inhibition in Pancreatic Adenocarcinoma
    Brian A. Boone et al, 2017, Clinical Colorectal Cancer CrossRef
  2. Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.
    Simon Heine et al, 2018, J Hematol Oncol CrossRef
  3. Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.
    Lokman Varisli et al, 2020, Immunology CrossRef
  4. Targeting Autophagy in Breast Cancer
    Stefania Cocco et al, 2020, IJMS CrossRef
  5. Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
    Bashir Lawal et al, 2021, Biomedicines CrossRef
  6. Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges
    Marika A. V. Reinius et al, 2021, Expert Rev. Mol. Med. CrossRef
  7. mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
    Angel Cayo et al, 2021, IJMS CrossRef
  8. Analyzing the scaffold diversity of cyclin‐dependent kinase inhibitors and revisiting the clinical and preclinical pipeline
    Deendyal Bhurta et al, 2021, Med Res Rev CrossRef
  9. Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
    Oana-Maria Thoma et al, 2021, Front. Pharmacol. CrossRef
  10. The Intricate Interplay between Cell Cycle Regulators and Autophagy in Cancer
    Dorian V. Ziegler et al, 2021, Cancers CrossRef
  11. TCP1 mediates gp37 of avian leukosis virus subgroup J to inhibit autophagy through activating AKT in DF-1 cells
    Xinheng Zhang et al, 2022, Veterinary Microbiology CrossRef
  12. Flavopiridol Protects against Fungal Keratitis due to Aspergillus fumigatus by Alleviating Inflammation through the Promotion of Autophagy
    Lingwen Gu et al, 2022, ACS Infect. Dis. CrossRef
  13. The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators
    Toshiya Fujisaki et al, 2022, FEBS Letters CrossRef
  14. Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer
    Zhaoliang Yu et al, 2024, Proc. Natl. Acad. Sci. U.S.A. CrossRef